Acutus Medical, Inc. (AFIB)
- Previous Close
0.0410 - Open
0.0415 - Bid --
- Ask --
- Day's Range
0.0386 - 0.0505 - 52 Week Range
0.0360 - 0.9900 - Volume
648,040 - Avg. Volume
1,222,014 - Market Cap (intraday)
1.685M - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4100 - Earnings Date Aug 5, 2024 - Aug 9, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
www.acutusmedical.com230
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: AFIB
Performance Overview: AFIB
Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AFIB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AFIB
Valuation Measures
Market Cap
1.22M
Enterprise Value
19.73M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.13
Price/Book (mrq)
0.16
Enterprise Value/Revenue
2.07
Enterprise Value/EBITDA
-0.26
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-13.80%
Return on Equity (ttm)
-32.16%
Revenue (ttm)
7.16M
Net Income Avi to Common (ttm)
-11.92M
Diluted EPS (ttm)
-0.4100
Balance Sheet and Cash Flow
Total Cash (mrq)
22.4M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
8.17M
Research Analysis: AFIB
Company Insights: AFIB
AFIB does not have Company Insights